MX9602981A - Benzalkonium fluoride injectable solution. - Google Patents

Benzalkonium fluoride injectable solution.

Info

Publication number
MX9602981A
MX9602981A MX9602981A MX9602981A MX9602981A MX 9602981 A MX9602981 A MX 9602981A MX 9602981 A MX9602981 A MX 9602981A MX 9602981 A MX9602981 A MX 9602981A MX 9602981 A MX9602981 A MX 9602981A
Authority
MX
Mexico
Prior art keywords
injectable solution
benzalkonium fluoride
solution
benzalkonium
fluoride
Prior art date
Application number
MX9602981A
Other languages
Spanish (es)
Other versions
MXPA96002981A (en
Inventor
Pierre Bourbon
Pierre Lagny
Original Assignee
Aromafarm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aromafarm Ltd filed Critical Aromafarm Ltd
Priority claimed from PCT/FR1995/000070 external-priority patent/WO1995019766A1/en
Publication of MXPA96002981A publication Critical patent/MXPA96002981A/en
Publication of MX9602981A publication Critical patent/MX9602981A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Intravascular delivery solution comprising in the region of or less than 0.23 percent by weight of at least one benzalkonium fluoride dissolved in an excipient injectable by intravascular means. The solution of the invention is useful for treating viral or infectious diseases, and especially immunodeficiency diseases.
MX9602981A 1995-01-23 1995-01-23 Benzalkonium fluoride injectable solution. MX9602981A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR94/00695 1994-01-24
FR9400695 1994-01-24
PCT/FR1995/000070 WO1995019766A1 (en) 1994-01-24 1995-01-23 Benzalkonium fluoride injectable solution

Publications (2)

Publication Number Publication Date
MXPA96002981A MXPA96002981A (en) 1998-01-01
MX9602981A true MX9602981A (en) 1998-01-31

Family

ID=39164843

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602981A MX9602981A (en) 1995-01-23 1995-01-23 Benzalkonium fluoride injectable solution.

Country Status (1)

Country Link
MX (1) MX9602981A (en)

Similar Documents

Publication Publication Date Title
BG100974A (en) Vaccines against papillomavirus
GR3031004T3 (en) HIV protease inhibitors
AU3216695A (en) Lipid analogs for treating viral infections
ES2174273T3 (en) USE OF HEPARINE OR HEPARAN-SULFATE IN COMBINATION WITH QUITOSAN FOR THE PREVENTION OR TREATMENT OF INFECTIONS CAUSED BY VIRUS HERPES.
TW284683B (en)
ITFI920078A0 (en) PROCESS FOR THE ISOLATION OF HIGHLY PURIFIED FACTOR IX, FACTOR X AND FACTOR II FROM PROTROMBIN COMPLEX OR HUMAN PLASMA.
HK1043809A1 (en) Pharmaceutical composition for treating papillomavirus tumours and infection.
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
AU6169298A (en) Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combinationtherapy for treating hepatitis virus infections
HK1012016A1 (en) Polyethyleneglycol hirudin conjugate, process of preparation and use in the cure of thrombosis
EP0621788A4 (en) Hemoregulatory peptides.
MX9602981A (en) Benzalkonium fluoride injectable solution.
CA2285463A1 (en) A combination therapy for hiv infections
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
UA41338C2 (en) Method for inhibiting retroviral infection caused by human immunodeficiency virus (hiv), method for inhibiting human immunodeficiency virus (hiv)
GB9207798D0 (en) Complexes of poladenylic acid polyuridylic acid
GR3015469T3 (en) 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS.
ATE128733T1 (en) MONOCLONAL ANTIBODIES AGAINST HIV GP120.
HU9403783D0 (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
DE59506747D1 (en) METHOD FOR PRODUCING A VIRUS-SAFE, THERAPEUTIC, BIOLOGICAL PREPARATION
ZA929176B (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b e)azepine-6,11-dione-11-oximes.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
MX9801104A (en) Remedy for coxsackie virus b infection.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees